Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Intangibles (2020 - 2025)

Historic Intangibles for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$5.7 million.

  • SOPHiA GENETICS's Intangibles rose 268.19% to -$5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year increase of 268.19%. This contributed to the annual value of -$7.7 million for FY2024, which is 358.82% down from last year.
  • Latest data reveals that SOPHiA GENETICS reported Intangibles of -$5.7 million as of Q3 2025, which was up 268.19% from -$3.2 million recorded in Q2 2025.
  • SOPHiA GENETICS's 5-year Intangibles high stood at $30.0 million for Q1 2025, and its period low was -$7.5 million during Q4 2023.
  • For the 5-year period, SOPHiA GENETICS's Intangibles averaged around $3.4 million, with its median value being -$2.8 million (2022).
  • In the last 5 years, SOPHiA GENETICS's Intangibles crashed by 11995.83% in 2022 and then skyrocketed by 181459.19% in 2023.
  • Over the past 5 years, SOPHiA GENETICS's Intangibles (Quarter) stood at -$3.9 million in 2021, then tumbled by 50.86% to -$5.8 million in 2022, then fell by 28.33% to -$7.5 million in 2023, then surged by 488.24% to $29.0 million in 2024, then tumbled by 119.65% to -$5.7 million in 2025.
  • Its Intangibles stands at -$5.7 million for Q3 2025, versus -$3.2 million for Q2 2025 and $30.0 million for Q1 2025.